Meeting Banner
Abstract #0281

Distinction Between Pure Steatosis and NASH Using a Fat Quantification Method in Combination with Liver Intravoxel Incoherent Motion Imaging in MRI at 3.0 T.

Benjamin Leporq1, Frank Pilleul1, 2, Jerome Dumortier3, Olivier Guillaud3, Thibaud Lefort3, Olivier Beuf1

1CREATIS; CNRS UMR 5220; INSERM U1044; INSA-Lyon; UCBL, Universit de Lyon, Villeurbanne, Rhne-Alpes, France; 2CHU Edouard Herriot; Department of digestive imaging, Hospices Civils de Lyon, Lyon, Rhne-Alpes, France; 3CHU Edouard Herriot; Department of Hepatology, Hospices Civils de Lyon, Lyon, Rhne-Alpes, France

Distinction between pure steatosis and NASH in patients with NAFLD is clinically important and drives the therapeutic strategy. While histology after liver biopsy is the gold standard for liver steatosis diagnosis and to establish the distinction between NASH and pure steatosis, inherent risk with a recognized morbidity and mortality, inter-observer variability and sampling errors renders this method unsuitable for longitudinal clinical monitoring, in particularly on children. Non-invasive quantification methods have been developed to quantify liver fat content. Nevertheless, these latter are not able to separate pure steatosis and NASH. Aim of this study was to evaluate the combination of liver intra-voxel incoherent motion imaging (IVIM) and a MRI fat quantification method at 3.0 T to make the distinction between NASH and pure steatosis. Preliminary results suggested that combining a fat quantification method with IVIM could be a relevant none invasive mean to evaluate steatosis severity and distinguish between pure steatosis and NASH.

Abstract PDF Presentation Video

Keywords

according accounting accumulation acknowledgments acquisition acquisitions addition aggressive alcoholic allow alone another applied averaging axial becoming biopsies biopsy body breathing brunt carcinoma channel children clinical clinically coefficient coefficients combination complexity complications component computed concern confounding constitute content control correcting cost decrease decreased density despite developed diabetes diffusion discovery diseases disjointed distinction distinguish dominant done drive duration effective evaluate evolves example exponential fibrosis fifteen form fraction framework furthermore grade grid growing health hospices hypertension illustrated incoherent indeed inflammation inherent inter intra invasive involved known linear lipid liver local maps materials matrix micro mild model moderate molecular monitoring mono motion obesity observer optimization others overload parametric particularly past patient patients perfusion pixel prevalence problematic procedure proton public pure quantification radiology random realized recognized reduce related renders repeated respectively risk scored separate seven severity significantly slices spectrum square stage started starting still strategy subgroups subjects system taken therapeutic thick threshold unsuitable volume volunteers water